참고자료

[조류독감] 신종 조류 기원 Influenza A (H7N9)의 인간 전염(NEJM)

중국 정부 소속 과학자들이 신종 조류 기원 Influenza A (H7N9)에 감염된 3명의 중국인
환자에게서 채취한 샘플에 대해 유전자 분석을 실시한 결과를 뉴잉글랜드저널오브메디신
(NEJM)에 기고한 논문입니다.

신종 H7N9 바이러스는 조류에 기원을 둔 것이었으나  NA 유전자는 H7N9 virus (KO14)와
밀접한 연관이 있었으며, HA 유전자는 중국 저장성에서 확인된  H7N3 virus (ZJ12)와 유사한
것으로 확인되었다고 합니다.

내부의 모든 유전자 조각들은 베이징에서 분리된 avian H9N2 viruses(BJ16)와 밀접한
연관이 있었다고 합니다. 

중국과 주변 국가에서 조류, 돼지, 인간의 인플루엔자 바이러스에 대한 유전적 분석 자료가
거의 없는 상황이라 현재로서는 어떤 숙주 동물의 체내에서 조류 기원 Influenza A (H7N9)
바이러스의 유전자 재조합이 일어났는지 밝혀낼 수 없다고 합니다.(돼지를 비롯한 포유동물
체내에서 조류 기원 Influenza A (H7N9) 유전자 재조합이 일어났는지 규명할 수 없다는
의미입니다)
 
예전에 조류 기원 H7 유형의 바이러스는 인간에게 전염된 바 있다는 보고가 있으나 N9 유형의
바이러스가 인간에게 전염되었다는 보고는 전혀 없었습니다.

이번에 분석한 3명의 환자에게 감염된 조류 기원 Influenza A (H7N9) 바이러스는 병독성이
강하며, 급속도로 중증 폐렴으로 진행되며, 결국에는 사망을 초래했습니다. (고열과 중증
하부 호흡기 감염증 증상이 특징적으로 나타났습니다)


================================


Original Article


Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus


Rongbao Gao, M.D., Bin Cao, M.D., Yunwen Hu, M.D., Zijian Feng, M.D., M.P.H., Dayan Wang, M.D., Wanfu Hu, M.D., Jian Chen, M.D., Zhijun Jie, M.D., Haibo Qiu, M.D., Ph.D., Ke Xu, M.D., Xuewei Xu, M.D., Hongzhou Lu, M.D., Ph.D., Wenfei Zhu, M.D., Zhancheng Gao, M.D., Nijuan Xiang, M.D., Yinzhong Shen, M.D., Zebao He, M.D., Yong Gu, M.D., Zhiyong Zhang, M.D., Yi Yang, M.D., Ph.D., Xiang Zhao, M.D., Lei Zhou, M.D., Xiaodan Li, M.D., Shumei Zou, M.D., Ye Zhang, M.D., Xiyan Li, M.D., Lei Yang, M.D., Junfeng Guo, M.D., Jie Dong, M.D., Qun Li, M.D., Libo Dong, M.D., Yun Zhu, M.D., Tian Bai, M.D., Shiwen Wang, M.D., Pei Hao, M.D., Weizhong Yang, M.D., Yanping Zhang, M.D., Jun Han, M.D., Hongjie Yu, M.D., Dexin Li, M.D., George F. Gao, Ph.D., Guizhen Wu, M.D., Yu Wang, M.D., Zhenghong Yuan, Ph.D., and Yuelong Shu, Ph.D.


April 11, 2013DOI: 10.1056/NEJMoa1304459


http://www.nejm.org/doi/full/10.1056/NEJMoa1304459?query=featured_home




Sporadic human infections with avian influenza A viruses, which usually occur after recent exposure to poultry, have caused a wide spectrum of illness, ranging from conjunctivitis and upper respiratory tract disease to pneumonia and multiorgan failure. Low pathogenic avian influenza A (H7N2, H7N3, H9N2, or H10N7)1-4 virus infections have caused lower respiratory tract illness that is mild (conjunctivitis or uncomplicated influenza-like illness) to moderate in severity. Most human infections with highly pathogenic avian influenza (HPAI) A (H7) viruses have resulted in conjunctivitis (H7N3) or uncomplicated influenza illness, but one case of fatal acute respiratory distress syndrome (ARDS) was reported in a patient with H7N7 virus infection during an outbreak in the Netherlands.1,5 In contrast, the cumulative case fatality rate since 2003 for reported cases of HPAI H5N1 virus infection is approximately 60%.6-8


The transmission of H7 viruses to mammals has been reported only rarely9 in Asia. Human infections with N9 subtype viruses had not been documented anywhere in the world. In February and March 2013, three patients were hospitalized with severe lower respiratory tract disease of unknown cause. We report the identification of a novel avian-origin reassortant influenza A (H7N9) virus associated with these infections.



Methods



Surveillance, Reporting, and Data Collection


Throat-swab specimens obtained from three adult Chinese patients (two from Shanghai City and one from Anhui Province) who were hospitalized with severe bilateral pneumonia, leukopenia, and lymphocytopenia were sent to Shanghai Public Health Clinical Center, the Shanghai Centers for Disease Control and Prevention (CDC), and the Anhui CDC, respectively. After preliminary detection of respiratory pathogens, the samples were sent to the Chinese National Influenza Center (CNIC) on March 25, 2013.


A standardized surveillance reporting form was used to collect epidemiologic and clinical data, including demographic characteristics; underlying medical conditions; history of seasonal influenza vaccination; recent exposures to swine, poultry, or other animals; recent visits to a live animal market; clinical signs and symptoms; chest radiographic findings; laboratory testing results, including diagnostic testing for influenza and other respiratory viruses; antiviral treatment; clinical complications; and outcomes. A confirmed case of human infection with avian-origin influenza A (H7N9) virus was defined as evidence of pneumonia with H7N9 viral RNA or isolation of H7N9 virus from respiratory specimens at the CNIC.



Isolation of the Virus


Throat-swab specimens obtained from all three patients were maintained in a viral-transport medium. The specimens were propagated in the allantoic sac and amniotic cavity of 9-to-11-day-old specific pathogen-free embryonated chicken eggs for 48 to 72 hours at 35°C.



RNA Extraction and Real-Time RT-PCR


RNA was extracted from throat-swab samples with the use of the QIAamp Viral RNA Mini Kit (Qiagen), according to the manufacturer’s instructions. Specific real-time reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assays for seasonal influenza viruses (H1, H3, or B), H5N1, severe acute respiratory syndrome coronavirus (SARS-CoV), and novel coronavirus were used. Real-time RT-PCR assays with self-designed specific primer and probe sets for detecting H1 to H16 and N1 to N9 subtypes were then performed to verify the viral subtypes.



Genome Sequencing and Phylogenetic Analysis


A total of 198 primer sets were used to amplify the full genome for sequencing, with the use of Qiagen OneStep RT-PCR Kit. PCR products were purified from agarose gel with the use of the QIAquick Gel Extraction Kit (Qiagen). We performed the sequencing using an ABI 3730xl automatic DNA analyzer (Life Technologies) and the ABI BigDye Terminator v3.1 cycle sequencing kit (Life Technologies), according to the manufacturer’s recommendations. Full genome sequences of the viruses from these patients were deposited in the Global Initiative on Sharing Avian Influenza Data (GISAID) database on March 29, 2013 (accession numbers are provided in Table S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org).


We performed multiple sequence alignments with the ClustalW program using MEGA software, version 5.05. Phylogenetic trees were constructed by means of the neighbor-joining method with the use of MEGA software, version 5.05, to estimate the viral gene relationship with selected influenza A virus strains obtained from GenBank.




Results



Patients


Patient 1 was an 87-year-old man with chronic obstructive pulmonary disease (COPD) and hypertension who reported a cough and sputum production at the onset of illness. High fever and dyspnea developed 1 week after the onset of illness. He had no known history of exposure to live birds during the 2 weeks before the onset of symptoms.


Patient 2 was a 27-year-old man with a history of hepatitis B virus infection with positive hepatitis B surface antigen who presented to the hospital with high fever and cough. This patient was a butcher who worked at a market where there were transactions involving live birds. He sold pork but had not butchered bird meat before the onset of illness. Both Patient 1 and Patient 2 lived in Min-hang District, Shanghai, and were admitted to the Fifth People’s Hospital.


Patient 3 was a 35-year-old woman who lived in Anhui Province. She had a history of depression, hepatitis B virus infection, and obesity. Patient 3 also had high fever and cough at the onset of the illness. She had visited a chicken market 1 week before the onset of symptoms. The demographic and epidemiologic characteristics of the three patients are summarized in Table 1Table 1Demographic, Epidemiologic, and Virologic Characteristics and Complications, Treatment, and Clinical Outcomes of Three Patients Infected with Avian-Origin Influenza A (H7N9) Virus..



Determination of Causative Pathogens


We confirmed, by means of real-time RT-PCR, viral isolation, and full genome sequencing, that all three patients were infected with a novel avian-origin influenza A (H7N9) virus. Original clinical samples obtained from all three patients were confirmed, by means of real-time RT-PCR, to be positive for H7N9 and negative for seasonal influenza viruses (H1, H3 or B), H5N1, SARS-CoV, and HCoV-Erasmus Medical Center (EMC). Influenza viruses A/Shanghai/1/2013 (H7N9), A/Shanghai/2/2013 (H7N9), and A/Anhui/1/2013 (H7N9) were isolated from Patients 1, 2, and 3, respectively. Complete sequences of the three H7N9 influenza viruses showed that they were 97.7 to 100% identical in all eight gene segments (see Table S1 in the Supplementary Appendix). Phylogenetic analysis of all genes of the isolates showed that each gene was of avian origin (Figure 1Figure 1Phylogenetic Trees of Genes of H7N9 Influenza A Viruses., and Figure S1 in the Supplementary Appendix). The gene encoding hemagglutinin (HA) shared the highest identity with A/duck/Zhejiang/12/2011 (H7N3, subtype ZJ12). The gene encoding neuraminidase (NA) protein was most closely related to A/wild bird/Korea/A14/2011 (H7N9, subtype KO14); however, the HA gene from the H7N9 viruses in our three patients was highly divergent from that in the KO14 virus. All six internal genes shared the highest similarity with A/brambling/Beijing/16/2012-like viruses (H9N2) (Figure 1). Phylogenetic results indicated that it was a triple reassortant H7N9 virus (Figure 2Figure 2Hypothetical Host and Lineage Origins of the Gene Segments of the Novel Reassortant Human Influenza A (H7N9) Viruses.).


In all three viruses, the HA cleavage site possesses only a single amino acid R (arginine), indicating low pathogenic effects in poultry. A T160A mutation was identified at the 150-loop (H3 numbering) in the HA gene of all three viruses. Substitution Q226L at the 210-loop in the HA gene was found in both the A/Anhui/1/2013 and A/Shanghai/2/2013 viruses but not in the A/Shanghai/1/2013 virus (Table 2Table 2Molecular Analysis of Three of the 2013 H7N9 Viruses.). Five amino acids were deleted in the stalk region of NA residue 69 to 73. The M2 protein contained the S31N substitution, indicating resistance to amantadine. Other mutations — 89V and E627K in PB2 and 42S in NS1 — were also identified (Table 2). The amino acids in A/Shanghai/1/2013, which differed from those in A/Anhui/1/2013 and A/Shanghai/2/2013, are shown in Table S2 in the Supplementary Appendix. To date, five additional H7N9 viruses have been isolated from five patients. Sequencing analysis indicates that all five viruses are highly similar to both A/Shanghai/2/2013 and A/Anhui/1/2013. Some variability is observed, such as Q226L in HA and R292K in NA.


On the basis of these data, diagnostic tests for the novel reassortant H7N9 viruses have been developed. The specific sequences are available on the website of the World Health Organization (www.who.int/influenza/gisrs_laboratory/a_h7n9/en/).



Clinical Features and Outcomes of the Patients


The clinical characteristics of the patients are shown in Table S3 in the Supplementary Appendix. Fever and cough were the most common symptoms. The white-cell count was normal or slightly decreased. Elevated levels of aspartate aminotransferase, creatine kinase, and lactate dehydrogenase were observed in all the patients. Bilateral ground-glass opacities and consolidation were detected on chest radiography (Figure 3Figure 3Chest Radiographs.).


Several complications of the illness were observed. All the patients had ARDS. Patient 3 had septic shock and acute renal damage. Carbapenem-resistant Acinetobacter baumannii was cultured from lower respiratory tract specimens obtained from two of the patients after the initiation of mechanical ventilation. Combination antibiotic therapy, glucocorticoids, and intravenous immunoglobulin were administered in all three patients. Antiviral therapy was initiated 6 to 7 days after the onset of illness (Table 1).


Patient 1 declined admission to the intensive care unit (ICU) and intubation. He died from refractory hypoxemia 13 days after the onset of illness. Patient 2 was admitted to the ICU and intubated 48 hours after admission owing to progressive dyspnea. He died from refractory hypoxemia after 4 days in the ICU. ARDS and septic shock developed in Patient 3 on day 6 after the onset of illness. She was admitted to the ICU, and extracorporeal membrane oxygenation was initiated. She died on April 9.




Discussion


We have identified a novel reassortant influenza A (H7N9) virus that is associated with severe human infection. Currently, only 25 H7N9 viruses are available in GenBank. The H7N9 viruses we identified in the three patients were of avian origin, but only the NA gene was closely related to that from another H7N9 virus (KO14). The HA gene was similar to that of an H7N3 virus (ZJ12) from a nearby region (Zhejiang Province) in China. All the internal gene segments were closely related to those from avian H9N2 viruses, particularly a virus isolated from a brambling in Beijing (BJ16) (Figure 1, and Figure S1 in the Supplementary Appendix). Thus, the human H7N9 viruses are the product of reassortment of viruses that are of avian-origin only. In addition, the phylogenetic trees showed that A/Shanghai/1/2013 is phylogenetically distinct from A/Anhui/1/2013 and A/Shanghai/2/2013 across all gene segments, which suggests that there have been at least two introductions into humans (Figure 1, and Figure S1 in the Supplementary Appendix). Currently, there are no data to suggest that this reassortment occurred in a mammalian host, and the similarity of the human viruses to avian viruses may be stronger support for direct avian transmission of this virus. However, influenza surveillance of birds, swine, and humans is limited in China and nearby countries, making it difficult to resolve this question.


Although human infections with avian-origin H7 avian influenza viruses have been observed before,1,2,5,10,11 infection of humans with an N9 subtype influenza virus has not been reported previously. Human H7 influenza infections are generally mild, causing conjunctivitis or modest respiratory symptoms, although a fatal case was reported before this H7N9 outbreak.5 All three cases of H7N9 infection reported here were virulent, with the patients’ conditions deteriorating rapidly with the development of severe pneumonia and ARDS, and ultimately resulted in death. All the patients had preexisting medical conditions, and two had a history of direct contact with poultry. Two patients presented with rhabdomyolysis, which has rarely been reported in patients infected with H1N1 or H5N112 influenza viruses. Encephalopathy, which is normally more common in pediatric patients with influenza,13 was observed in two patients.


The affinity of the influenza virus to different sialyl-sugar structures is an important determinant of range and pathogenicity in the viral host.14,15 Human influenza viruses preferentially bind to α2,6 sialyl glycan, whereas most avian viruses bind to α2,3 sialyl glycan.16,17 Q226L in the HA protein, which was first reported in H7 field viruses, as well as H5 subtypes, was expected to bind strongly to α-2,6 human-like receptors. A laboratory-produced Q226L mutation at the 210-loop of HA has been shown to change the receptor binding of avian origin to a human-type receptor binding and might increase the ability of the virus to be transmitted by air, as reported previously.18,19 Moreover, the lack of a glycosylation site on the 150-loop might decrease the affinity to α-2,3 avian-like receptors. The effects of these mutations require further study.


A deletion of five amino acids in the viral NA stalk has been observed in the novel reassortant H7N9 viruses. A similar deletion in the H5N1 avian virus has been shown to be responsible for the change in viral tropism to the respiratory tract20 or to enhance viral replication,21 and it has been suggested that this deletion may be associated with adaptation and transmission in domestic poultry.22,23 Since April 4, it has been reported that H7N9 viruses similar to those isolated from the three patients described here have been isolated from pigeons and chickens, indicating that the novel H7N9 viruses might currently be circulating in poultry. Moreover, the E627K substitution in the PB2 gene has been associated with increased virulence in mice and was reported to be associated with improved replication of avian influenza viruses in mammals.24,25 A combination of these substitutions may contribute to the human infection and severe disease. Other possible virulence molecular markers are shown in Table 2. The potential virulence mutations are described on the basis of previous studies in animals, but the pathogenesis in humans remains unknown.


The difference between the two Shanghai viruses and the similarity between the Shanghai/2 and Anhui/1 viruses argue against human-to-human transmission in these cases, and no close contacts of the patients have tested positive for these viruses. However, limited human-to-human transmission was observed in the H7 outbreak in the Netherlands in 200310; therefore, the pandemic potential of these novel avian-origin viruses should not be underestimated.


Currently there is no vaccine available for these novel viruses, and it is not known whether the current candidate H7 vaccine viruses, of which three are North American viruses and the other three are avian viruses from 2000 in the Netherlands, may be effective. The influenza H7N9 A/Anhui/1/2013 strain has been proposed to be one of the candidate vaccine strains since it grows to a very high titer in eggs. Heightened protective measures should be taken when dealing with these viruses, and increased surveillance and analyses of these viruses are needed.


Severe avian influenza A (H7N9) infections, characterized by high fever and severe respiratory symptoms, may pose a serious human health risk. We are concerned by the sudden emergence of these infections and the potential threat to the human population. An understanding of the source and mode of transmission of these infections, further surveillance, and appropriate counter measures are urgently required.





Supported by a grant (2011CB504704) from the National Basic Research Program (973) of China, grants (81070005/H0104 and 81030032/H19) from the National Natural Science Foundation of China, grants from the China National Mega-projects for Infectious Diseases (2012ZX10004-211 to Dr. Yuan and 2013ZX10004-101 to Dr. Dexin Li), and the Chinese National Influenza Center–Centers for Disease Control and Prevention (CDC) collaborative project 5U51IP000334-03 from the CDC China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases.


The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention in China or other organizations.


Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.


This article was published on April 11, 2013, at NEJM.org.


We thank Prof. Chen Wang in Beijing Hospital, Ministry of Health, for his advice in clinical study, data analysis, and preparation of the manuscript; Dr. Yunde Hou (Chinese Center for Disease Control and Prevention) and Yumei Wen (Fudan University) for their suggestions and discussion; the staff at the National Health and Family Planning Commission for help with coordination; and personnel at the Chinese National Influenza Surveillance Network and National Sci-Tech Key Project of Infectious Disease Surveillance Laboratory Network, China.




Source Information


The authors’ affiliations are listed in the Appendix.


Address reprint requests to Dr. Shu at the National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, 155 Changbai Rd., Beijing, 102206, China, or at ; or to Dr. Yuan at the Key Lab of Medical Molecular Virology, School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shanghai City 200032, or at .


Drs. R. Gao, Cao, Y. Hu, Feng, D. Wang, W. Hu, Chen, Jie, and Qiu contributed equally to this study.



Appendix


The authors’ affiliations are as follows: the National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (R.G., D.W., W.Z., X.Z., X.L., S.Z., Y.Z., X.L., L.Y., J.G., J.D., L.D., Y.Z., T.B., S.W., J.H., D.L., G.W., Y.S.), Beijing Chao-Yang Hospital, Beijing Institute of Respiratory Diseases, Capital Medical University (B.C.), Chinese Center for Disease Control and Prevention (Z.F., N.X., L.Z., Q.L., W.Y., Y.Z., H.Y., G.F.G., Y.W.), and Peking University People’s Hospital (Z.G.), Beijing; Shanghai Public Health Clinical Center, Shanghai Medical College of Fudan University (Y.H., H.L., Y.S., Z.Z., Z.Y.), Shanghai Municipal Center for Disease Control and Prevention (J.C.), the Fifth People’s Hospital of Shanghai, Fudan University (Z.J., Z.H., Y.G.), and Institute Pasteur of Shanghai, Chinese Academy of Sciences (P.H.), Shanghai; Anhui Provincial Center for Disease Control and Prevention, Hefei (W.H.); Zhongda Hospital, Southeast University (H.Q., Y.Y.), and Jiangsu Provincial Center for Disease Prevention and Control (K.X.), Nanjing; and Chuzhou Center for Disease Control and Prevention, Chuzhou (X.X.) — all in China.


References




  1. 1


    Hirst M, Astell CR, Griffith M, et al. Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis 2004;10:2192-2195
    CrossRef | Medline



  2. 2


    Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill 2006;11:E060504.2.



  3. 3


    Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill 2007;12:E070531.2.



  4. 4


    Arzey GG, Kirkland PD, Arzey KE, et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis 2012;18:814-816
    CrossRef | Medline



  5. 5


    Fouchier RA, Schneeberger PM, Rozendaal FW, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004;101:1356-1361
    CrossRef | Web of Science | Medline



  6. 6


    Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467-471
    CrossRef | Web of Science | Medline



  7. 7


    Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003;362:1733-1745
    CrossRef | Web of Science | Medline



  8. 8


    Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007;20:243-267
    CrossRef | Web of Science | Medline



  9. 9


    Kwon TY, Lee SS, Kim CY, Shin JY, Sunwoo SY, Lyoo YS. Genetic characterization of H7N2 influenza virus isolated from pigs. Vet Microbiol 2011;153:393-397
    CrossRef | Medline



  10. 10


    Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004;363:587-593
    CrossRef | Medline



  11. 11


    Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004;10:2196-2199
    CrossRef | Medline



  12. 12


    D’Silva D, Hewagama S, Doherty R, Korman TM, Buttery J. Melting muscles: novel H1N1 influenza A associated rhabdomyolysis. Pediatr Infect Dis J 2009;28:1138-1139
    CrossRef | Medline



  13. 13


    Ekstrand JJ. Neurologic complications of influenza. Semin Pediatr Neurol 2012;19:96-100
    CrossRef | Medline



  14. 14


    Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 2005;3:591-600
    CrossRef | Medline



  15. 15


    Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 2005;28:399-408
    CrossRef | Medline



  16. 16


    Ito T, Kawaoka Y. Host-range barrier of influenza A viruses. Vet Microbiol 2000;74:71-75
    CrossRef | Medline



  17. 17


    Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000;69:531-569
    CrossRef | Medline



  18. 18


    Herfst S, Schrauwen EJ, Linster M, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012;336:1534-1541
    CrossRef | Medline



  19. 19


    Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012;486:420-428
    CrossRef | Medline



  20. 20


    Sorrell EM, Song H, Pena L, Perez DR. A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens. J Virol 2010;84:11831-11840
    CrossRef | Medline



  21. 21


    Baigent SJ, McCauley JW. Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res 2001;79:177-185
    CrossRef | Medline



  22. 22


    Guan Y, Peiris JS, Lipatov AS, et al. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A 2002;99:8950-8955
    CrossRef | Web of Science | Medline



  23. 23


    Li J, Zu Dohna H, Cardona CJ, Miller J, Carpenter TE. Emergence and genetic variation of neuraminidase stalk deletions in avian influenza viruses. PLoS One 2011;6:e14722-e14722
    CrossRef | Medline



  24. 24


    Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001;293:1840-1842
    CrossRef | Web of Science | Medline



  25. 25


    Labadie K, Dos Santos Afonso E, Rameix-Welti MA, van der Werf S, Naffakh N. Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology 2007;362:271-282
    CrossRef | Medline

    =========================


中国学者发H7N9病毒研究报告:流行潜力不能低估



2013年04月15日 13:13
来源:中国新闻网
http://news.ifeng.com/mainland/special/h7n9/content-3/detail_2013_04/15/24230115_0.shtml

原标题:中国学者发H7N9病毒研究报告:流行潜力不能低估


中新网4月15日电 据中国疾病预防控制中心网站消息,中国疾病预防控制中心网站15日刊文称,《新英格兰医学杂志》在线发表中国科学家的最新研究成果论文《人感染新型H7N9禽流感病毒》,介绍了我国科学家发现人感染H7N9禽流感病毒的重要成果和意义。研究成果显示,新型重配的H7N9禽流感病毒的流行潜力不能低估,最重要的是要密切关注该病毒的进化情况,尤其要严密监测其是否可能在人际间传播。


文章介绍,今年3月下旬,针对上海、安徽等地报告的疑似新发疾病,中国疾控中心、上海公共卫生临床中心、上海市第五人民医院、上海市疾控中心、安徽省疾控中心等单位专家集体协作攻关,在短时间内确定了一种从未发现的可导致人类肺炎的新型病原体,成功确认导致该疾病的病原是一个新的重配H7N9亚型禽流感病毒。文章对该病毒的全基因序列的关键基因进行了综合分析,对疾病的临床特征进行了描述,提示了病人的禽类接触史。


文章表示,目前,新型H7N9禽流感病毒在什么时间、什么地点以及如何出现,仍没有科学的证据和解释。由于该病毒感染可造成高病死率,作者建议在加强防护措施的同时,加快针对新H7N9禽流感病毒疫苗和抗病毒药物的研发。


针对我国学者发表的这项研究论文,美国疾病预防与控制中心流感研究和参比合作中心南希博士等人在同期杂志上发表评论文章,称中国科学家的发现具有重要的公共卫生意义。

댓글 남기기

이메일은 공개되지 않습니다.

다음의 HTML 태그와 속성을 사용할 수 있습니다: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>